Pure Global
NCT06368089

Short Effects of SIMT and EM in Prolonged Mechanically Ventilated Patients

Short Effects of Speci|c Inspiratory Muscle Training and Early Mobilization in Prolonged Mechanically Ventilated Patients
Prince of Songkla University·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ventilator Dependent
Drug/Device/Intervention
Inspiratory muscle training (IMT) group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Prince of Songkla University
Location
Songkhla, Thailand
Timeline & enrollment
Phase
N/A
Start date
May 24, 2024
End date
Mar 01, 2026
Enrollment
46 participants
Primary outcome

Maximum inspiratory pressure (MIP),Dynamic lung compliance (Cdyn)

Summary

Using mechanical ventilation for more than 18 hours can affect respiratory muscle and
 postural muscle control, making it difficult to wean off the ventilator and reducing
 mobility. The aim of this study is to:
 
 1. Compare the effects of respiratory muscle strength training and early mobilization on
 dynamic lung compliance and maximum inspiratory pressure before and after a 7-day
 training period.
 
 2. Compare the success rate of weaning and the duration of weaning between the respiratory
 muscle strength training and the early mobilization program.

ICD-10 classifications
Dependence on respiratorDependence on aspiratorRespiratory conditions due to other specified external agentsRespiratory conditions due to unspecified external agentRespiratory conditions due to other external agents
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06368089
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06368089 through Pure Global AI's free database. This phase not specified trial is sponsored by Prince of Songkla University and is currently Not yet recruiting. The study focuses on Ventilator Dependent. Target enrollment is 46 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.